Adjuvant Dendritic Cell-immunotherapy Plus Temozolomide in Glioblastoma Patients
Adjuvant Dendritic Cell-immunotherapy Plus Temozolomide in Glioblastoma Patients
Active, not recruiting · NCT02649582 · Registry updated 2026-06-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Adjuvant Dendritic Cell-immunotherapy Plus Temozolomide in Glioblastoma Patients | brain glioblastoma | Active, not recruiting | Phase 1 / Phase 2 | 2026-06-04 | NCT02649582 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University Hospital, Antwerp | 108 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Antwerp University Hospital | Edegem | Belgium | 18 |